Accéder au contenu
Merck

Evaluation of benzoic acid derivatives as sirtuin inhibitors.

Bioorganic & medicinal chemistry letters (2013-11-26)
Yi-Pei Chen, Chad C Catbagan, Jeannette T Bowler, Trevor Gokey, Natalie D M Goodwin, Anton B Guliaev, Weiming Wu, Taro Amagata
RÉSUMÉ

Employing a genetically modified yeast strain as a screening tool, 4-dimethylaminobenzoic acid (5) was isolated from the marine sediment-derived Streptomyces sp. CP27-53 as a weak yeast sirtuin (Sir2p) inhibitor. Using this compound as a scaffold, a series of disubstituted benzene derivatives were evaluated to elucidate the structure activity relationships for Sir2p inhibition. The results suggested that 4-alkyl or 4-alkylaminobenzoic acid is the key structure motif for Sir2p inhibitory activity. The most potent Sir2p inhibitor, 4-tert-butylbenzoic acid (20), among the tested compounds in this study turned out to be a weak but selective SIRT1 inhibitor. The calculated binding free energies between the selected compounds and the catalytic domain of SIRT1 were well correlated to their measured SIRT1 inhibitory activities.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-tert-Butylbenzoic acid, 99%